Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
D004341:Drug Evaluation; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D008935:Mitoguazone / Q000009:adverse effects / Q000627:therapeutic use*; D009437:Neuralgia / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D006146:Guanidines; D008935:Mitoguazone